DF
CVS icon

Donoghue Forlines’s CVS Health CVS Stock Holding History

Donoghue Forlines’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.83M Sell
17,657
-4,335
-20% -$387K 0.47% 70
2026
Q1 		$1.58M Buy
21,992
+3,161
+17% +$244K 0.44% 94
2025
Q4 		$1.49M Sell
18,831
-1,283
-6% -$101K 0.46% 76
2025
Q3 		$1.52M Sell
20,114
-2,304
-10% -$158K 0.47% 76
2025
Q2 		$1.55M Sell
22,418
-25
-0.1% -$1.64K 0.44% 67
2025
Q1 		$1.52M Sell
22,443
-8,744
-28% -$523K 0.48% 70
2024
Q4 		$1.4M Buy
+31,187
New +$1.75M 0.47% 98
2022
Q3 		– Sell
-5,416
Closed -$502K – 248
2022
Q2 		$502K Sell
5,416
-5,038
-48% -$492K 0.13% 220
2022
Q1 		$1.06M Sell
10,454
-1,660
-14% -$174K 0.23% 123
2021
Q4 		$1.25M Buy
+12,114
New +$1.12M 0.21% 92
2021
Q3 		– Sell
-13,670
Closed -$1.14M – 210
2021
Q2 		$1.14M Sell
13,670
-3,095
-18% -$253K 0.21% 115
2021
Q1 		$1.26M Buy
+16,765
New +$1.22M 0.24% 101

Other funds holding CVS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Donoghue Forlines's CVS Position: Q2 2026 in Review

Donoghue Forlines reduced its CVS Health (CVS) stake by 20% in Q2 2026, selling an estimated $387K and leaving 17,657 shares worth $1.83M. The position accounts for 0.47% of the portfolio, ranked #70.

Donoghue Forlines first reported a position in CVS in Q1 2021 and has held it in 12 quarters since. 2,067 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • Donoghue Forlines held 17,657 shares of CVS Health worth $1.83M as of Q2 2026.
  • Donoghue Forlines sold 4,335 CVS Health shares in Q2 2026, an estimated $387K.
  • CVS Health made up 0.47% of Donoghue Forlines's portfolio in Q2 2026, its #70 holding.
  • Donoghue Forlines first reported a position in CVS Health in Q1 2021 and has held it in 12 quarters since.
  • 2,067 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Donoghue Forlines's 13F filing for Q2 2026, filed 7 Aug 2026.